Fitoterapia

Fitoterapia 由 Elsevier 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Natural product bioactivities and synthesis、Phytochemistry and Biological Activities、Essential Oils and Antimicrobial Activity 等主题的论文，这 3 个主题约占 36.6%。（根据 OpenAlex 主题统计与中科院分区数据生成）

The Journal for the Study of Medicinal PlantsA Q1-ranked journal in the category of 'Agricultural and Biological Sciences' (Scopus).Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in six major areas:Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes Innovative analytical approaches for dereplication and standardization of bioactive extracts and metabolites from plant resources Identification of bioactivity in plant and fungal extracts and in their constituents Identification of biological targets and mechanism of activity of plant and fungal extracts Production and genomic characterization of medicinal plants biomass Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues. Publication requirementsWestern Blots. Manuscripts reporting Western Blots must include original uncropped traces in triplicate as Supplementary Material. Images should be of good resolution.NMR data. Manuscripts reporting the structure elucidation of new compounds must include copies of MS and 1D and 2D NMR spectra as Supplementary Material. Fitoterapia strongly encourages Authors to deposit raw NMR data files (FID and 2D serial files) for new compounds in a publicly accessible data depository. Reviews. For review article submissions, Authors are required to provide evidence of their expertise and research experience in the specific field. Contributions reporting the following are NOT considered for publication: Activity data on crude extracts that have not been characterized by qualitative (and preferably quantitative) analysis of their individual constituents (LC/MS, or isolation followed by NMR). Data on the extract composition simply taken from literature or from previous studies are not acceptable. Characterization of only a few constituents is generally considered too partial. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. Unexceptional and predictable bioactivity (e.g. antioxidant and mild antimicrobial properties of phenolics or of essential oils). Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.Studies based exclusively or mainly on computational/theoretical investigations without adequate experimental support.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal (e.g. investigation on extracts obtained from animal sources) RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified (with scientific Latin names), authenticated, and documented (voucher). RULE 4: Lack of the required supporting material (see publication requirements). RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature. RULE 7: Bibliometric or patentometric reviews.

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-药学

主编 Orazio Taglialatela-Scafati出版商官网

编委会国家分布：中国大陆 21 位（约 34%）；主要国家 中国 21、意大利 8、德国 6、美国 4、英国 2（共 61 位编委标注了国家） 编委会 ↗出版商官网 · 2026-10-01

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

2.88LetPub · 2026-09-13

影响因子（出版商公布）

2.9出版商官网 · 2026-10-01

CiteScore 2026-06

3.9LetPub · 2026-09-13

CiteScore（出版商公布）

3.9出版商官网 · 2026-10-01

SJR 2026-06

0.51LetPub · 2026-09-13

SNIP 2026-06

0.9LetPub · 2026-09-13

h-index

90LetPub · 2026-09-13

h-index

147OpenAlex · 2026-10-01

i10-index

4,509OpenAlex · 2026-10-01

两年平均被引

3OpenAlex · 2026-10-01

自引率

6.9%LetPub · 2026-09-13

Gold OA 文章占比

8.69%LetPub · 2026-09-13

发文规模

年文章数

581LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

平均1.0个月来源Elsevier官网：平均1.6周LetPub · 2026-09-13

平均录用比例（社区反馈）

75%LetPub · 2026-09-13

投稿到接收

88 天出版商官网 · 2026-10-01

接收到发表

2 天出版商官网 · 2026-10-01

评审方式

单盲同行评审出版商官网

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Elsevier

出版国家或地区

NETHERLANDS

出版语言

English

出版周期

Bimonthly

创刊年份

1947

ISSN

0367-326X

电子版 ISSN

1873-6971

官方链接

• 期刊主页 ↗LetPub
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网